REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,386,827 | -80.6% | 120,909 | -57.1% | 0.00% | -100.0% |
| Q2 2023 | $7,141,116 | -23.6% | 282,146 | -2.7% | 0.00% | 0.0% |
| Q1 2023 | $9,340,899 | +187.7% | 290,000 | +64.9% | 0.00% | – |
| Q4 2022 | $3,247,279 | -72.0% | 175,909 | -59.0% | 0.00% | -100.0% |
| Q3 2022 | $11,596,000 | +700.3% | 429,471 | +309.3% | 0.00% | – |
| Q2 2022 | $1,449,000 | +113.1% | 104,922 | +201.0% | 0.00% | – |
| Q1 2022 | $680,000 | -62.7% | 34,862 | -68.7% | 0.00% | – |
| Q4 2021 | $1,821,000 | -7.3% | 111,537 | +58.2% | 0.00% | – |
| Q3 2021 | $1,965,000 | -4.4% | 70,520 | +1.7% | 0.00% | – |
| Q2 2021 | $2,056,000 | +3.2% | 69,325 | -2.8% | 0.00% | – |
| Q1 2021 | $1,993,000 | +16.0% | 71,310 | +17.7% | 0.00% | – |
| Q4 2020 | $1,718,000 | -22.9% | 60,608 | -31.6% | 0.00% | – |
| Q3 2020 | $2,228,000 | +59.9% | 88,629 | +55.4% | 0.00% | – |
| Q2 2020 | $1,393,000 | +74.8% | 57,049 | +5.9% | 0.00% | – |
| Q1 2020 | $797,000 | +55.1% | 53,863 | +70.1% | 0.00% | – |
| Q4 2019 | $514,000 | -6.7% | 31,671 | -25.3% | 0.00% | – |
| Q3 2019 | $551,000 | -0.4% | 42,396 | -0.5% | 0.00% | – |
| Q2 2019 | $553,000 | -57.4% | 42,595 | -48.3% | 0.00% | – |
| Q1 2019 | $1,297,000 | +31.4% | 82,323 | +67.8% | 0.00% | – |
| Q4 2018 | $987,000 | -51.9% | 49,053 | -40.6% | 0.00% | – |
| Q3 2018 | $2,052,000 | -38.1% | 82,600 | -31.6% | 0.00% | -100.0% |
| Q2 2018 | $3,315,000 | +252.7% | 120,757 | +295.8% | 0.00% | – |
| Q1 2018 | $940,000 | +177.3% | 30,509 | +221.7% | 0.00% | – |
| Q4 2017 | $339,000 | +23.3% | 9,483 | -4.9% | 0.00% | – |
| Q3 2017 | $275,000 | +82.1% | 9,973 | +73.4% | 0.00% | – |
| Q2 2017 | $151,000 | 0.0% | 5,753 | -20.6% | 0.00% | – |
| Q1 2017 | $151,000 | +30.2% | 7,247 | +29.5% | 0.00% | – |
| Q4 2016 | $116,000 | +182.9% | 5,596 | +122.3% | 0.00% | – |
| Q3 2016 | $41,000 | -16.3% | 2,517 | -29.9% | 0.00% | – |
| Q2 2016 | $49,000 | +69.0% | 3,592 | +115.5% | 0.00% | – |
| Q1 2016 | $29,000 | -94.7% | 1,667 | -89.5% | 0.00% | – |
| Q4 2015 | $544,000 | +1331.6% | 15,926 | +1168.0% | 0.00% | – |
| Q3 2015 | $38,000 | -51.9% | 1,256 | -48.9% | 0.00% | – |
| Q2 2015 | $79,000 | +259.1% | 2,456 | +138.9% | 0.00% | – |
| Q1 2015 | $22,000 | -70.7% | 1,028 | -76.6% | 0.00% | – |
| Q4 2014 | $75,000 | +188.5% | 4,400 | +221.4% | 0.00% | – |
| Q3 2014 | $26,000 | -42.2% | 1,369 | +2.4% | 0.00% | – |
| Q2 2014 | $45,000 | +40.6% | 1,337 | +33.7% | 0.00% | – |
| Q1 2014 | $32,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |